When standard therapy doesn’t provide sufficient relief, it’s reasonable to ask about other options. Many people with OCD engage fully in evidence-based care and still experience persistent symptoms.

In recent years, treatment options have expanded beyond traditional behavioral approaches alone. Over the past decade, research has expanded the range of alternative treatments for OCD. These include FDA-permitted brain-based interventions and medication strategies that target different neural pathways involved in the disorder.

For those with partial or incomplete responses to first-line care, ongoing symptoms can continue to interfere with daily life. In these cases, considering additional, research-supported treatments is a practical next step, not a failure of therapy.

Why Standard Treatments Don’t Work for Everyone

Obsessive-compulsive disorder (OCD) affects millions of people and is often misunderstood or diagnosed late. It involves intrusive, unwanted thoughts, such as fears about contamination, harm, taboo ideas, or the need for symmetry. These signs drive repetitive behaviors meant to reduce anxiety. While these compulsions may bring short-term relief, they often reinforce the cycle and interfere with daily life.

The standard treatment approach combines cognitive behavioral therapy with exposure and response prevention (ERP). It also includes medications like selective serotonin reuptake inhibitors (SSRIs). ERP helps people gradually face feared thoughts or situations without engaging in compulsions, retraining the brain’s response to anxiety over time.

However, even with proper, evidence-based care, many people experience only partial improvement. Persistent symptoms have led researchers to explore additional strategies, including medication augmentation and brain-based interventions. This growing body of research reflects a broader understanding that OCD involves multiple brain systems, not just serotonin. This also helps explain why some individuals require treatments beyond first-line approaches.

What Are OCD Symptoms and How Is It Diagnosed?

Before exploring new treatments for OCD, it’s important to understand what defines this condition and how it’s properly diagnosed.

OCD is often confused with obsessive-compulsive personality disorder (OCPD), but the two are different. OCPD involves long-standing personality traits such as perfectionism and rigidity, while the presence of true obsessions and compulsions defines OCD.

OCD symptoms typically include:

  • Obsessions: Intrusive, unwanted thoughts that cause significant anxiety (e.g., contamination fears, harm fears, taboo thoughts, need for order)
  • Compulsions: Repetitive behaviors or mental acts performed to reduce anxiety (e.g., washing, checking, counting, reassurance-seeking)

For a diagnosis of OCD, symptoms must be time-consuming (typically more than one hour per day) or cause significant distress or interference with daily functioning. This impact often shows up as difficulty concentrating at work or school, strained relationships, and trouble completing everyday tasks.

New OCD Treatments

In recent years, OCD care has expanded beyond SSRIs and weekly ERP sessions. These latest OCD treatment options fall into three categories:

  • Brain-based interventions
  • Medications that work beyond serotonin
  • New ways of delivering proven therapy

These options do not replace ERP, but they extend treatment for people who don’t fully respond to first-line care.

1. Brain-Based Interventions

Deep Transcranial Magnetic Stimulation (Deep TMS)

Transcranial magnetic stimulation (TMS) is an FDA-cleared, non-invasive brain stimulation treatment for adults with OCD who haven’t achieved sufficient relief from medication or ERP.

In 2018, the FDA cleared the first Deep TMS system for OCD. Since then, additional TMS systems and protocols have also received FDA clearance, expanding access to this treatment option.

Deep TMS uses a specialized coil design that allows stimulation to reach broader brain regions involved in OCD, including circuits that regulate fear, decision-making, and habit formation. Clinical studies reviewed by the FDA showed that active TMS treatment led to meaningful symptom improvement compared with sham stimulation.

OCD-specific TMS protocols often include brief symptom activation exercises before stimulation to engage relevant brain circuits. Side effects are usually mild and short-lived, such as headache or scalp discomfort, and people can return to normal activities immediately after sessions.

Accelerated Theta Burst Stimulation (TBS)

Accelerated TBS is a newer way of delivering TMS that focuses on speed and convenience. Instead of one session per day over several weeks, it uses many short sessions each day over just a few days, aiming to deliver results more quickly.

This approach has already shown faster improvement in depression and is now being studied for OCD. While early findings are promising, accelerated TBS for OCD is still experimental. Researchers are also continuing to study how well it works, how long the benefits last, and who it helps most.

Deep Brain Stimulation (DBS)

Deep brain stimulation is used only for the most severe and long-standing cases of OCD, when symptoms have not improved with medication, ERP, or non-invasive treatments like TMS.

The procedure involves surgically placing small electrodes in specific brain areas to help regulate abnormal activity linked to OCD. Long-term studies show that some carefully selected patients experience meaningful and lasting symptom improvement. Because it requires brain surgery and ongoing medical care, DBS is considered a last-resort treatment and is available only at specialized centers.

MRI-Guided Focused Ultrasound (MRgFUS)

MRgFUS is a non-incisional neurosurgical technique that uses focused ultrasound guided by MRI to target overactive brain circuits involved in OCD precisely.

In long-term follow-up studies, many patients with severe, treatment-resistant OCD maintained significant symptom improvement for years after the procedure. Despite these results, MRgFUS remains a highly specialized option reserved for individuals who have exhausted all other evidence-based treatments.

2. Neurochemical Approaches Beyond Serotonin

Glutamate-Modulating Treatments

Research increasingly shows that OCD also involves glutamate dysregulation. This has led to interest in medications that work through different brain pathways than SSRIs.

N-Acetylcysteine (NAC)

NAC is one of the most studied glutamate-modulating agents for OCD. Research shows modest but meaningful symptom improvement in some individuals, particularly when added to existing medication. Typical doses range from 2,000 to 3,000 mg per day, with generally mild side effects.

Other Glutamatergic Agents

Several medications are being studied as add-on treatments, including memantine and lamotrigine. Results are mixed, and these medications are considered off-label and adjunctive, not first-line treatments. Some investigational drugs have been discontinued after unsuccessful trials, underscoring the importance of ongoing research.

Ketamine and Esketamine

Ketamine has shown rapid but short-term symptom relief in small OCD studies. Effects are thought to involve glutamate signaling and brain plasticity. However, benefits are often temporary, and long-term protocols are still being studied. Evidence for esketamine in OCD is currently limited compared to depression.

3. New Ways of Delivering Therapy (Intensive Formats)

Some of the most meaningful advances in OCD care aren’t new therapies, but new ways of delivering ERP more effectively.

Bergen Four-Day Treatment (B4DT)

B4DT compresses ERP into an intensive four-day format with individualized treatment delivered in a structured group setting. Studies show large symptom reductions that are often maintained over time. Many participants report high satisfaction and willingness to recommend the program.

This approach uses well-established ERP principles but delivers them in a way that can improve engagement, learning, and momentum.

Response Disequilibrium Therapy (RDx)

RDx is an emerging behavioral approach that links access to rewarding daily activities with reducing compulsive behaviors. Early case studies suggest potential benefit, but RDx currently lacks large randomized trials and should be considered experimental.

The technique empowers clients to implement their own procedures outside therapy sessions, potentially offering a more sustainable way to manage symptoms without requiring constant clinical supervision.

Choosing the Right Approach for You

Understanding these emerging approaches is just the first step. The key is knowing how to evaluate and assess them appropriately.

When considering newer therapies, several important factors deserve attention:

  • Consult With a Specialist: OCD care has become increasingly specialized. Working with clinicians experienced in these approaches ensures you receive evidence-based care rather than experimental therapies without proven benefit. Look for providers who understand both standard approaches and newer alternatives.
  • Remember That Standard Therapies Remain Foundational: Even advanced options often work best when combined with exposure and response prevention. Emerging choices aren’t meant to replace ERP but to enhance it or provide alternatives when standard care proves insufficient.
  • Be Patient With Ongoing Research: Many of these therapies are still being studied through randomized controlled trials. What succeeds in clinical trials doesn’t always translate perfectly to real-world settings. Long-term data collection is still underway for several approaches.
  • Recognize That Individual Response Varies: What works well for one person may not work for another. A treatment plan should be tailored to your specific needs, particular thought patterns, and individual circumstances.
  • Verify Insurance Coverage Before Proceeding: While Deep TMS is FDA-cleared for OCD, insurance coverage may not be available in all cases. Before pursuing these options, contact your insurance provider to learn about prior authorization requirements, the documentation your clinician needs, the number of sessions covered, and out-of-pocket costs.
  • Consider Practical Factors: Time commitment varies widely. Deep TMS protocols typically involve multiple sessions over several weeks. Intensive formats like B4DT condense care into 4 days. Medications require ongoing management. Choose options that fit your schedule and lifestyle.

Expert OCD Care Tailored to Your Journey

At Serenity Mental Health Centers, we specialize in providing personalized, science-based care for OCD and related mental health conditions. Our experienced psychiatrists stay at the forefront of mental health innovation, offering access to the latest evidence-based approaches. These include many of the breakthrough options discussed in this article. We understand that traditional methods don’t work for everyone, which is why we take a holistic, individualized approach to your care.

When you choose Serenity, you’ll work closely with a dedicated psychiatrist who takes the time to truly understand your unique needs, concerns, and experiences. From comprehensive evaluations to customized treatment plans, we’re here to guide you on your journey to recovery with compassion and expertise. Whether you’re seeking help with intrusive thoughts, compulsive behaviors, or related anxiety disorders, our team has the experience to provide relief and improve your daily life.

Ready to explore your options? Contact Serenity Mental Health Centers or request an appointment online to schedule a consultation with one of our OCD specialists today.